Why is Maitreya Medica. falling/rising?

As of 24-Sep, Maitreya Medicare Ltd is currently priced at 240.00, showing no change (0.00%). The stock has underperformed in the short term, with a 1-week return of -2.81% and a 1-month return of -4.00%. Despite outperforming its sector by 0.62% today, Maitreya Medicare is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The company has a low Debt to EBITDA ratio of 0.30 times, indicating a strong ability to service debt, but its return on equity (ROE) is only 5.9, and the stock has seen a significant decline in profits, with a year-over-year return of -37.21% and a profit drop of -40%. Additionally, the operating profit has decreased at an annual rate of -22.52% over the last five years, contributing to a negative sentiment around the stock.
In the broader market context, Maitreya Medicare's recent performance contrasts with the Sensex, which has shown a 1-week decline of only -1.08% and a 1-month increase of +0.75%. This indicates that while the stock is facing challenges, the overall market is not performing as poorly. The liquidity of the stock remains adequate, with a delivery volume increase of 66.67% against the 5-day average, suggesting some investor interest despite the negative financial indicators. Overall, the combination of poor long-term growth prospects and declining profitability has led to a bearish outlook for Maitreya Medicare, contributing to its current price stagnation.